Literature DB >> 2334212

Dexamethasone treatment for congenital adrenal hyperplasia.

M C Young1, I A Hughes.   

Abstract

Ten patients with congenital adrenal hyperplasia (three males, seven females; aged 12-29 years) had their usual glucocorticoid treatment changed to dexamethasone in three crossover dosage regimens. A starting dose of 5 micrograms/kg/day is suggested but as no one dose regimen resulted in adequate control the timing of the dose must be decided for each patient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334212      PMCID: PMC1792315          DOI: 10.1136/adc.65.3.312

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

Review 1.  Management of congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

2.  Single dose dexamethasone in treatment of congenital adrenocortical hyperplasia.

Authors:  A Hayek; J D Crawford; H H Bode
Journal:  Metabolism       Date:  1971-09       Impact factor: 8.694

3.  Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.

Authors:  J Winterer; G P Chrousos; D L Loriaux; G B Cutler
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  Effects of long term dexamethasone treatment in adult patients with congenital adrenal hyperplasia.

Authors:  P M Horrocks; D R London
Journal:  Clin Endocrinol (Oxf)       Date:  1987-12       Impact factor: 3.478

5.  170H-progesterone rhythms in congenital adrenal hyperplasia.

Authors:  M C Young; J A Robinson; G F Read; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

  5 in total
  8 in total

Review 1.  Growth in congenital adrenal hyperplasia.

Authors:  An Tt Nguyen; Justin J Brown; Garry L Warne
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

Review 2.  Adrenal steroidogenesis and congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

3.  Low-dose dexamethasone therapy from infancy of virilizing congenital adrenal hyperplasia.

Authors:  Scott A Rivkees; Kerry Stephenson
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-14

4.  Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the "growth toxic" glucocorticoid.

Authors:  Scott A Rivkees
Journal:  Int J Pediatr Endocrinol       Date:  2010-04-15

Review 5.  Novel treatment strategies in congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-06       Impact factor: 3.243

6.  Nocturnal Dexamethasone versus Hydrocortisone for the Treatment of Children with Congenital Adrenal Hyperplasia.

Authors:  Andrew Dauber; Henry A Feldman; Joseph A Majzoub
Journal:  Int J Pediatr Endocrinol       Date:  2010-09-14

7.  Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis.

Authors:  Emma Whittle; Henrik Falhammar
Journal:  J Endocr Soc       Date:  2019-04-18

8.  Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Jamie L Renbarger; Zeina M Nabhan; Sydney E Ross; James E Slaven; Lang Li; Emily C Walvoord; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2016-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.